Tour de Fox 2016 cycling series raises nearly $1m for Parkinson’s
Author: Almaz OhenePublished: 22 September 2016
Prep: Cook: Serves:
More than 5,700 individual donors supported the Tour de Fox 2016 series where 900 cyclists raised US$800,000 for Parkinson’s research
The Tour de Fox 2016 cycle series, which took place in three different cycling events locations in the US and Canada in July and August, saw more than 900 cyclists – just under 70 of those cyclists have Parkinson’s themselves – tackle rides of between 10 and 75 miles to raise money for the Michael J Fox Foundation.
In a blog post, Tour de Fox founder, Sam Fox, writes: “Those 900 riders inspired an incredible 5,700 individual donations for their efforts from friends, family, and generous strangers.
“All added up, the Tour has raised an impressive $800,000 (and counting!) to help close the gap on a cure.”
Sam Fox continued: “Continuing the trend set in 2015, the Tour de Fox Series was once again a big success. And once again, that success came from our passionate community of fundraisers.
“It has been amazing to see a project that was originally inspired by my own mother, grow and evolve into something that is capable of reaching people across the continent. Thanks to so many – our riders, their friends and families, our sponsors, and of course our volunteers – the Tour de Fox will continue to thrive, inspire, and raise crucial programmatic dollars for years to come. Thanks for coming out, and hope to see you all next year!”
Tour de Fox is the brainchild of ultra-athlete and Michael J Fox Foundation staffer Sam Fox (no relation to Michael J Fox) combining his athletic skills with his entrepreneurial spirit to raise funds for research and honour his mother, Lucy, who has lived with Parkinson’s disease since 2000.
His first big fundraiser for the Foundation was in 2011, when he ran around 2,500 miles from US-Canada border to the US-Mexico border.
In 2015, Sam undertook a 14,000-mile odyssey across the US and Canada. Over the three-month period, he climbed 49 high points in 48 states and travelled a total of 14,000 miles – 8,000 of those by bike – on his way to raising more than US$2.45 million.
Parkinson’s UK to launch largest plant-based oil trial in the world
The trial will be carried out over three years
3 weeks ago
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.
Could frailty be a potential risk factor for Parkinson’s disease?
Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”